causal
US Market Subsidizes Global Drug Innovation
Because foreign governments negotiate drug prices down to near cost while the United States allows manufacturers to charge monopoly prices (with Medicare barred from negotiating), 50% or more of a new drug's profits come from the US market, making the rest of the world free-riders on American consumers who fund the innovation.
causalpending
Speaker
Russ RobertsEvidence Quote
“we here in Israel and elsewhere around the world are free-riding on the only place where manufacturers can make money.”
Created: 6/13/2026, 12:24:14 AM
Your notes
Loading notes...